Efficacy of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis

被引：0
|
作者：
Kani, C. [1 ]
Papanikolaou, K. [2 ]
Pehlivanidis, A. [3 ]
Papadopoulou-Daifoti, Z. [1 ]
机构：
[1] Univ Athens, Dept Pharmacol, Sch Med, Athens, Greece
[2] Univ Athens, Dept Child Psychiat, Agia Sophia Childrens Hosp, Athens, Greece
[3] Univ Athens, Dept Psychiat 1, Eginit Hosp, Athens, Greece
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2008年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S505 / S505
页数：1
相关论文
共 50 条
  • [1] Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials
    Kavirajan, Harish
    Schneider, Lon S.
    [J]. LANCET NEUROLOGY, 2007, 6 (09): : 782 - 792
  • [2] Efficacy of Cholinesterase Inhibitors in Vascular Dementia: An Updated Meta-Analysis
    Chen, Yu-dan
    Zhang, Juan
    Wang, Yue
    Yuan, Jun-liang
    Hu, Wen-li
    [J]. EUROPEAN NEUROLOGY, 2016, 75 (3-4) : 132 - 141
  • [3] Efficacy of cholinesterase inhibitors and memantine in Alzheimer's disease: a meta-analysis
    Kani, C.
    Papanikolaou, K.
    Pehlivanidis, A.
    Papadopoulou-Daifoti, Z.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 : S505 - S506
  • [4] Cholinesterase inhibitors and memantine for Parkinson's disease dementia and Lewy body dementia: A meta-analysis
    Meng, Yan-Hong
    Wang, Pan-Pan
    Song, Ya-Xue
    Wang, Jian-Hua
    [J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 17 (03) : 1611 - 1624
  • [5] Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta-analysis
    Battle, Ceri E.
    Abdul-Rahim, Azmil H.
    Shenkin, Susan D.
    Hewitt, Jonathan
    Quinn, Terry J.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (02):
  • [6] Comparative Efficacy and Acceptability of Cholinesterase Inhibitors and Memantine Based on Dosage in Patients with Vascular Cognitive Impairment: A Network Meta-analysis
    Shi, Xinxiu
    Ren, GuangHao
    Cui, Yang
    Xu, ZhongXin
    [J]. CURRENT ALZHEIMER RESEARCH, 2022, 19 (02) : 133 - 145
  • [7] Cost-Effectiveness: Cholinesterase Inhibitors and Memantine in Vascular Dementia
    Wong, Camilla L.
    Bansback, Nick
    Lee, Philip E.
    Anis, Aslain H.
    [J]. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2009, 36 (06) : 735 - 739
  • [8] Tolerability of memantine in combination with cholinesterase inhibitors in Alzheimer's disease and vascular dementia
    Hartmann, S
    [J]. NEUROBIOLOGY OF AGING, 2002, 23 (01) : S84 - S84
  • [9] Cholinesterase inhibitors and memantine for symptomatic treatment of dementia
    Rodda, Joanne
    Carter, Janet
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2012, 344
  • [10] Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis
    Wang, Hui-Fu
    Yu, Jin-Tai
    Tang, Shao-Wen
    Jiang, Teng
    Tan, Chen-Chen
    Meng, Xiang-Fei
    Wang, Chong
    Tan, Meng-Shan
    Tan, Lan
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2015, 86 (02): : 135 - 143
12345